| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.4 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |